Newsletter March 2022
Bertrand Loisel
Unified Patent Court
The Unified Patent Court (UPC) Agreement signed in 2013 is a breakthrough for pan-European patent (...)
Marie Govaert, Denis Bourgarel
Clinical trials : implementation of the new regulation
Implementation of the new European clinical trials regulation 536/2014 on medicinal products for (...)
Article
Isabelle Labarre, Catherine Touati
Certificat Complémentaire de Protection
This article is also available in French. In January 2022, the UP/UPC (Unitary Patent and Unified (...)
Newsletter January 2022
Isabelle Labarre
Patent Term Extension
On June 01, 2021, the fourth amendment of Patent Law in China entered into effect.  This amendment (...)
Newsletter January 2022
Alexandre Decreton, Albert Hassine
Non-employed inventors
Two new articles of the French Law, in force since December 2021, provide the automatic devolution (...)
Newsletter January 2022
Fabian Lieb
 German Patent Act
Injunctions: reducing the gap and the hardship - 31 months for German phase entry The German (...)
Newsletter January 2022
Laurence Loumes
pacte law
In 2019, a series of new laws came into force with the goal of strengthening the French economy. (...)
Newsletter January 2022
Bertrand Loisel
European patent
The end of a headache for applicants? In a decision T 1989/18 of December 16, 2021, the Board of (...)
Newsletter September 2021
Mathias Robert
Patent eligibility
Artificial intelligence enables machines to learn from experience and mimic human behavior on (...)
Article
Laurence Loumes , Mathias Robert
patent eligibility
The first hurdle to patent an invention in the USA is to pass the patent eligibility bar of 35 U.S. (...)
Newsletter June 2021
Atom Tong Xi Jun
Chinese patent law
China is one of the most dynamic and promising economies in the world. In order to meet the demands (...)
Article
Mathias Robert, Denis Bourgarel
Artificial Intelligence and Drug Development
Artificial intelligence (AI), like any other previous General Purpose Technology, is pervasive, (...)